top of page
Islet_edited.jpg

ISLET ALLO TRANSPLANTATION

 IN PATIENTS WITH KIDNEY GRAFT

IAK patient info

OPEN ENROLLMENT

Pancreatic Islet Allo Transplantation

in Patients with Stable Kidney Graft Function

​

Funded Internally

​

Islet after Kidney Transplantation 

​

I am writing to let you know about an opportunity to participate in a research study designed for patients with Type 1 Diabetes who has already received a kidney transplant.

 

The study may benefit especially for those patients with challenging blood glucose control.

 

This study is being conducted by myself, Dr. Piotr Witkowski at the University of Chicago.

​

This research study will assess the safety, tolerability and efficacy of the islet transplantation in patients with stable islet allograft function.

​

You may be eligible for this study if:

  • you have Type 1 Diabetes

  • you are between the ages of 18-65,

  • you have stable kidney graft function

  • blood type A or AB

  • you have BMI below 30

​

If you are interested in learning more about this study, contact our Clinical Study Manager Lindsay Basto, RN, BSN, 

Lindsay.Basto@uchicago.edu for more information.

​

It is important to know that this letter is not to tell you to join the study.

It is your decision, and your participation is voluntary.

Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors. 

​

Thank you for your interest and consideration, 

 

Piotr Witkowski M.D. Ph.D​​

CONTACT:

ucm-logo.png

Piotr 

Witkowski

Laboratory

University of Chicago Medicine

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

Transplantation Institute
Clinical  Research Center

Islet  Transplantation
Direct contact:
Isletcelltx@bsd.uchicago.edu

Donate to
our research  >> 
  • Facebook
  • Twitter

© 2018 by Kajetan Witkowski

bottom of page